These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 26414667)
1. Tet oncogene family member 2 gene alterations in childhood acute myeloid leukemia. Li MJ; Yang YL; Lee NC; Jou ST; Lu MY; Chang HH; Lin KH; Peng CT; Lin DT J Formos Med Assoc; 2016 Sep; 115(9):801-6. PubMed ID: 26414667 [TBL] [Abstract][Full Text] [Related]
2. TET2 mutations in acute myeloid leukemia (AML): results from a comprehensive genetic and clinical analysis of the AML study group. Gaidzik VI; Paschka P; Späth D; Habdank M; Köhne CH; Germing U; von Lilienfeld-Toal M; Held G; Horst HA; Haase D; Bentz M; Götze K; Döhner H; Schlenk RF; Bullinger L; Döhner K J Clin Oncol; 2012 Apr; 30(12):1350-7. PubMed ID: 22430270 [TBL] [Abstract][Full Text] [Related]
3. The prognostic impact of tet oncogene family member 2 mutations in patients with acute myeloid leukemia: a systematic-review and meta-analysis. Wang R; Gao X; Yu L BMC Cancer; 2019 Apr; 19(1):389. PubMed ID: 31023266 [TBL] [Abstract][Full Text] [Related]
4. Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Abdel-Wahab O; Mullally A; Hedvat C; Garcia-Manero G; Patel J; Wadleigh M; Malinge S; Yao J; Kilpivaara O; Bhat R; Huberman K; Thomas S; Dolgalev I; Heguy A; Paietta E; Le Beau MM; Beran M; Tallman MS; Ebert BL; Kantarjian HM; Stone RM; Gilliland DG; Crispino JD; Levine RL Blood; 2009 Jul; 114(1):144-7. PubMed ID: 19420352 [TBL] [Abstract][Full Text] [Related]
5. [Analysis of clinical significance and prognostic impact of TET2 single nucleotide polymorphism I1762V in patients with acute myeloid leukemia]. Li YW; Guo Z; Wang LL; Zhou L; Lyu XD; Song YP Zhonghua Xue Ye Xue Za Zhi; 2022 Mar; 43(3):241-246. PubMed ID: 35405783 [No Abstract] [Full Text] [Related]
6. Prognostic significance of Tet methylcytosine dioxygenase 2 (TET2) gene mutations in adult patients with acute myeloid leukemia: a meta-analysis. Liu WJ; Tan XH; Luo XP; Guo BP; Wei ZJ; Ke Q; He S; Cen H Leuk Lymphoma; 2014 Dec; 55(12):2691-8. PubMed ID: 24524305 [TBL] [Abstract][Full Text] [Related]
7. TET2 missense variants in human neoplasia. A proposal of structural and functional classification. Bussaglia E; Antón R; Nomdedéu JF; Fuentes-Prior P Mol Genet Genomic Med; 2019 Jul; 7(7):e00772. PubMed ID: 31187595 [TBL] [Abstract][Full Text] [Related]
8. TET2 expression is a potential prognostic and predictive biomarker in cytogenetically normal acute myeloid leukemia. Zhang TJ; Zhou JD; Yang DQ; Wang YX; Wen XM; Guo H; Yang L; Lian XY; Lin J; Qian J J Cell Physiol; 2018 Aug; 233(8):5838-5846. PubMed ID: 29219176 [TBL] [Abstract][Full Text] [Related]
9. Clinical and biological impact of TET2 mutations and expression in younger adult AML patients treated within the EORTC/GIMEMA AML-12 clinical trial. Aslanyan MG; Kroeze LI; Langemeijer SM; Koorenhof-Scheele TN; Massop M; van Hoogen P; Stevens-Linders E; van de Locht LT; Tönnissen E; van der Heijden A; da Silva-Coelho P; Cilloni D; Saglio G; Marie JP; Tang R; Labar B; Amadori S; Muus P; Willemze R; Marijt EW; de Witte T; van der Reijden BA; Suciu S; Jansen JH Ann Hematol; 2014 Aug; 93(8):1401-12. PubMed ID: 24994606 [TBL] [Abstract][Full Text] [Related]
11. Correlation of TET2 SNP rs2454206 with improved survival in children with acute myeloid leukemia featuring intermediate-risk cytogenetics. Wang X; Chen X; Yang Z; Dou H; Lu L; Bi J; Zou L; Yu J; Bao L Genes Chromosomes Cancer; 2018 Aug; 57(8):379-386. PubMed ID: 29664232 [TBL] [Abstract][Full Text] [Related]
12. Hypomethylation of TET2 Target Genes Identifies a Curable Subset of Acute Myeloid Leukemia. Yamazaki J; Taby R; Jelinek J; Raynal NJ; Cesaroni M; Pierce SA; Kornblau SM; Bueso-Ramos CE; Ravandi F; Kantarjian HM; Issa JP J Natl Cancer Inst; 2015 Nov; 108(2):. PubMed ID: 26568194 [TBL] [Abstract][Full Text] [Related]
14. TET2 mutations in cytogenetically normal acute myeloid leukemia: clinical implications and evolutionary patterns. Damm F; Markus B; Thol F; Morgan M; Göhring G; Schlegelberger B; Krauter J; Heuser M; Bernard OA; Ganser A Genes Chromosomes Cancer; 2014 Oct; 53(10):824-32. PubMed ID: 24898826 [TBL] [Abstract][Full Text] [Related]
15. [Analysis of the Effect of TET2 Mutation and SNP on Clinical Characteristics and Prognosis of AML Patients]. Li L; An LC; Chu XX; Liu XQ; Wang L Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):453-459. PubMed ID: 32319378 [TBL] [Abstract][Full Text] [Related]
16. Next-generation sequencing with a myeloid gene panel in core-binding factor AML showed KIT activation loop and TET2 mutations predictive of outcome. Cher CY; Leung GM; Au CH; Chan TL; Ma ES; Sim JP; Gill H; Lie AK; Liang R; Wong KF; Siu LL; Tsui CS; So CC; Wong HW; Yip SF; Lee HK; Liu HS; Lau JS; Luk TH; Lau CK; Lin SY; Kwong YL; Leung AY Blood Cancer J; 2016 Jul; 6(7):e442. PubMed ID: 27391574 [TBL] [Abstract][Full Text] [Related]
17. [Clinical Significance of Truncated Mutant ΔJBP of TET2 Gene in Patients with Acute Myeloid Leukemia]. Yang YC; Xia T; Luo M; Guo WZ; Zhang LL; Chen XH; Xu ZF; Wang HW; Tan YH Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1011-1018. PubMed ID: 34362476 [TBL] [Abstract][Full Text] [Related]
18. TET2 deletions are a recurrent but rare phenomenon in myeloid malignancies and are frequently accompanied by TET2 mutations on the remaining allele. Bacher U; Weissmann S; Kohlmann A; Schindela S; Alpermann T; Schnittger S; Kern W; Haferlach T; Haferlach C Br J Haematol; 2012 Jan; 156(1):67-75. PubMed ID: 22017486 [TBL] [Abstract][Full Text] [Related]
19. TET2 mutations contribute to adverse prognosis in acute myeloid leukemia (AML): results from a comprehensive analysis of 502 AML cases and the Beat AML public database. Pan X; Chang Y; Ruan G; Zhou S; Jiang H; Jiang Q; Huang X; Zhao XS Clin Exp Med; 2024 Feb; 24(1):35. PubMed ID: 38349460 [TBL] [Abstract][Full Text] [Related]
20. Mutations in TET2 and DNMT3A genes are associated with changes in global and gene-specific methylation in acute myeloid leukemia. Ponciano-Gómez A; Martínez-Tovar A; Vela-Ojeda J; Olarte-Carrillo I; Centeno-Cruz F; Garrido E Tumour Biol; 2017 Oct; 39(10):1010428317732181. PubMed ID: 28992762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]